Hypoglycemia is the limiting factor in the management of diabetes
- PMID: 10398545
- DOI: 10.1002/(sici)1520-7560(199901/02)15:1<42::aid-dmrr1>3.0.co;2-b
Hypoglycemia is the limiting factor in the management of diabetes
Abstract
Hypoglycemia is the limiting factor, both conceptually and in practice, in the management of diabetes mellitus. While the long-term goal of diabetes research must remain the cure and the prevention of the disease and reasonable near-term goals might include perfect insulin replacement or prevention of complications despite ongoing hyperglycemia, the most pressing short-term goal for people with diabetes would seem to be insight leading to strategies that effectively minimize the risk of hypoglycemia and thus permit low-risk glycemic control. Having reviewed the field in detail recently, the author offers his personal views of the key questions - concerning the physiology of glucose counterregulation, its pathophysiology in diabetes, and hypoglycemia in diabetes - that, if answered, might lead to a reduced risk of iatrogenic hypoglycemia in people with diabetes. The overriding question is: How can we learn to replace insulin more perfectly, prevent, correct or compensate for compromised glucose counterregulation, or both?
Copyright 1999 John Wiley & Sons, Ltd.
Similar articles
-
Hypoglycemia in diabetes.Diabetes Care. 2003 Jun;26(6):1902-12. doi: 10.2337/diacare.26.6.1902. Diabetes Care. 2003. PMID: 12766131 Review.
-
Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.Diabetes. 1994 Nov;43(11):1378-89. doi: 10.2337/diab.43.11.1378. Diabetes. 1994. PMID: 7926315 Review.
-
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.N Engl J Med. 1985 Jul 25;313(4):232-41. doi: 10.1056/NEJM198507253130405. N Engl J Med. 1985. PMID: 2861565 Review.
-
Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges.Clin Ther. 2017 Aug;39(8S2):S1-S11. doi: 10.1016/j.clinthera.2016.09.020. Epub 2016 Nov 18. Clin Ther. 2017. PMID: 27871780 Review.
-
[Drug-induced hypoglycemia].Nihon Rinsho. 2007 Oct 28;65 Suppl 8:575-83. Nihon Rinsho. 2007. PMID: 18074605 Review. Japanese. No abstract available.
Cited by
-
Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.PLoS One. 2013;8(4):e59672. doi: 10.1371/journal.pone.0059672. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577069 Free PMC article. Clinical Trial.
-
Health Care Providers' Emotional Responses to Their Patients' Hypoglycemic Events: Qualitative Findings From the InHypo-DM Study, Canada.Diabetes Spectr. 2021 Nov;34(4):388-393. doi: 10.2337/ds20-0061. Epub 2021 May 26. Diabetes Spectr. 2021. PMID: 34866872 Free PMC article.
-
Modular closed-loop control of diabetes.IEEE Trans Biomed Eng. 2012 Nov;59(11):2986-99. doi: 10.1109/TBME.2012.2192930. Epub 2012 Apr 3. IEEE Trans Biomed Eng. 2012. PMID: 22481809 Free PMC article.
-
Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes.Front Physiol. 2012 Feb 28;3:40. doi: 10.3389/fphys.2012.00040. eCollection 2012. Front Physiol. 2012. PMID: 22403550 Free PMC article.
-
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes.Clinicoecon Outcomes Res. 2018 Jul 26;10:413-421. doi: 10.2147/CEOR.S169045. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 30100746 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical